Safety and Efficacy of DA-9805 for Parkinson's Disease

NCT03189563 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

61

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: DA-9805 45mg
DRUG: DA-9805 90mg
OTHER: Placebo

Sponsor

Dong-A ST Co., Ltd.